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Epidemiological ﬁndings indicate that hormonal inﬂuences may play a role in the etiology of renal cell cancer (RCC). The
possible effect of childbearing remains enigmatic; while some investigators have reported a positive association between
number of births and renal cell cancer risk, others have not. A case–control study, nested within a nation-wide Fertility
Register covering Swedish women born 1925 and later, was undertaken to explore possible associations between parity and
age at ﬁrst birth and the risk of renal cell cancer. Among these women a total of 1465 cases of RCC were identiﬁed in the
Swedish Cancer Register between 1958 and 1992 and information on the number of live childbirths and age at each birth was
obtained by linkage to the Fertility Database. For each case, ﬁve age-matched controls were randomly selected from the same
register. Compared to nulliparous women, ever-parous women were at a 40% increased risk of RCC (Odds Ratio [OR]=1.42;
95% CI 1.19-1.69). The corresponding OR for women of high parity (ﬁve or more live births) was 1.91 (95% CI 1.40–2.62).
After controlling for age at ﬁrst birth among parous women, each additional birth was associated with a 15% increase in risk
(OR=1.15; 95% CI 1.08–1.22). The observed positive association between parity and renal cell cancer risk is unlikely to be
fully explained by uncontrolled confounding, but warrants further evaluation in large studies, with allowance for body mass
index.
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Cancer of the renal parenchyma, or renal cell cancer (RCC), repre-
sents about 80% of all kidney cancer cases in Sweden and is about
twice as common in men than among women. Incidence rates in
Sweden have tended to decrease among both men and women
(Swedish Cancer Registry, 2000), during the past two decades in
contrast to many other areas in the world. Reported international
incidence rates vary more than 10-fold, with the highest rates
found in northern, western and eastern Europe, Australia and
North America (Ferlay et al, 2001). Apart from cigarette smoking
and obesity, and possibly weight cycling, hypertension and/or anti-
hypertensive medication, the causes of renal cell cancer are unclear
(McLaughlin and Lipworth, 2000).
Experimental ﬁndings of oestrogen-induced renal cell carcino-
genesis in animals (Li and Li, 1990) have prompted an interest
in the possible inﬂuence of hormonal factors in humans. Weak
positive associations have been reported for use of oral contracep-
tives (McLaughlin et al, 1992) and replacement oestrogens in some
(Asal et al, 1988; McLaughlin et al, 1992), but not all studies
(McLaughlin et al, 1984; Adami et al, 1998). A large case–control
study, however, found a reduced risk of renal cell cancer following
oral contraceptive use (Lindblad et al, 1995), although another
recent study found no relationship (Gago-Dominguez et al,
1999). Two studies showed no relation between hysterectomy or
oophorectomy and risk of RCC (Wynder et al, 1974; McLaughlin
et al, 1984), whereas other investigators have reported an increased
risk following hysterectomy (McCredie and Stewart, 1992; Mellem-
gaard et al, 1994; Gago-Dominguez et al, 1999) and both
hysterectomy and oophorectomy (Lindblad et al, 1995). There is
also some epidemiological evidence that childbearing may play a
role in the development of RCC (Kreiger et al, 1993; Chow et al,
1995; Lindblad et al, 1995).
To further examine this issue, we utilised a large population-
based data set to explore possible associations between pregnancy
and the risk of renal cell cancer among Swedish women.
MATERIALS AND METHODS
We merged data from two population-based Swedish registers, the
Fertility Register and the Cancer Register, both updated through
1992, through a unique national registration number.
The Fertility Register was originally based on women born
between 1925 and 1960 who were resident citizens of Sweden in
1960. For these women, reproductive data (nulliparity, number
and dates of live births) during the period 1943–1960 were
collected retrospectively at the 1960 Census. Later birth cohorts
of all Swedish women have been added continuously, with the
women’s births being recorded annually via vital statistics records.
For the present study, the Fertility Register included almost 3.4
million live births recorded from 1943 to 1992 among approxi-
mately 2.4 million women born between 1925 and 1972. Based
on a nation-wide reporting system of all births to women residing
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birth is generally high (Johansson and Finna ¨s, 1983). In the oldest
cohorts, mainly women born 1925–29, fertility may be underesti-
mated since children born before 1943, those not living with their
mothers, and those who died before the 1960 Census, were not
recorded. There might also be a slight overestimation of fertility
between 1943 and 1960 because adopted and foster children were
included in the retrospectively collected information. From 1961
and onwards, only biological children were included. Dates of
death and emigration among registered women are recorded yearly
in the Fertility Register. Because women with 10 or more births are
rare in the birth cohorts under study, complete birth dates were
only obtained for up to nine children per woman for the purpose
of this study. Subjects with 10 or more births were identiﬁable by a
two-digit parity code.
The Swedish Cancer Register started in 1958. All newly diag-
nosed malignant tumours must be reported to the Register
separately by both the clinician and the pathologist or cytologist.
Nearly 100% of all diagnosed cancers are recorded (Swedish Cancer
Registry, 2000). Among resident Swedish women born between
1925 and 1972, a total of 2086 cases of kidney cancer (International
Classiﬁcation of Diseases (ICD)-7:180) were recorded in the
Cancer Register from January 1, 1958 to December 31, 1992. Of
these, 1856 (88.9 %) were identiﬁed in the Fertility Register. Thus,
no match was achieved for 230 cases recorded in the Cancer Regis-
ter, some of which represent mismatches due to aberrant national
registration numbers, while the majority are non-Swedish citizens
who are recorded only in the Cancer Register. We excluded 14
cases diagnosed in 1958–1960 who were survivors with prevalent
cancers at the time of the 1960 Census, two cases with more than
nine children, 193 cases with non-renal cell cancer and 368 cases
with histopathological-codes other than adenocarcinoma (code:
096). Because of overlap between the excluded groups, the ﬁnal
analysis encompassed 1465 cases of renal cell cancer with concomi-
tant fertility information.
A nested case–control study was undertaken to evaluate
possible associations between the recorded reproductive variables
and RCC. For every case, ﬁve comparison women (controls)
matched on year and month of birth were randomly selected
among those in the Fertility Register. The controls had to be alive
at the date of the diagnosis of the case and be residents of Sweden,
without themselves having been diagnosed with kidney cancer.
Controls were assigned an index date that was the same as the
diagnosis date of their matched case. For both cases and controls,
only pregnancies before the date of the diagnosis of the case (the
index date for the control) were included in the analysis. Controls
with more than nine births were excluded, leaving ﬁve case–
control sets being matched 1:4.
Statistical analysis
The statistical analyses used matched conditional logistic regression
(Breslow and Day, 1980). Associations between the reproductive
risk factors and RCC were measured using odds ratios (OR) as
estimates of relative risks (Rothman and Greenland, 1998), and
their 95% conﬁdence intervals (CI). Age at ﬁrst birth was analysed
both as a categorical variable (nulliparous, 520, 20–24, 25–29,
30+) and as a continuous variable in the analysis for parous
women. Risk estimates with time since most recent pregnancy were
calculated among uniparous, biparous and triparous women,
compared to nulliparous women.
RESULTS
More than half of all renal cell cancers (59.9%) in women were
diagnosed at age 50 or over (Table 1), with a mean age at diag-
nosis of 50.4 years. We found a strong positive association
between number of births and risk of RCC (Table 2). Compared
to nulliparous women, ever parous women were at a 40%
increased risk of RCC (OR=1.42; 95% CI=1.19–1.69). The corre-
sponding OR for women of high parity (ﬁve or more live births)
was 1.91 (95% CI=1.40–2.62). After controlling for age at ﬁrst
birth among parous women, risk increased monotonically and
each additional birth was associated with a 15% increase in risk
(OR=1.15; 95% CI=1.08–1.22). Relative to uniparous women,
the adjusted odds ratio for women with three births was 1.33
(95% CI=1.10–1.61) and for women with ﬁve or more births
the OR was 1.62 (95% CI=1.18–2.23) (Table 2). The positive
association with parity was similar in women older at diagnosis
(age 550 years) and in those younger at diagnosis (550 years)
(data not shown). When age at ﬁrst birth was analysed as a
continuous variable, there was a slight decrease in risk with
increasing age at ﬁrst delivery. After controlling for parity among
parous women, the risk decreased by 8% for each 5-year incre-
ment of delay of ﬁrst birth (OR=0.92; 95% CI=0.86–1.00)
(Table 2).
Table 3 shows the risk of developing RCC by years since most
recent birth among uniparous, biparous, triparous and ever-parous
women relative to nulliparous women. Except for women with one
live birth, risk estimates were consistently and often signiﬁcantly
elevated in all time periods since delivery.
DISCUSSION
The inﬂuence of number of births on the risk of RCC remains
unclear with a majority of studies ﬁnding no clear relation
(Wynder et al, 1974; McLaughlin et al, 1984, 1992; Cantor et al,
1993; La Vecchia et al, 1993; Mellemgaard et al, 1994; Gago-
Dominguez et al, 1999), while some investigators have reported
positive associations (Kreiger et al, 1993; Chow et al, 1995; Lind-
blad et al, 1995).
Our results indicate that women with a history of high parity
are at an increased risk of renal cell cancer. Compared to nulli-
parous women, the risk was nearly two times higher among
women with ﬁve or more live births. This ﬁnding is in agreement
with that of a large international multi-centre case–control study
that found an 80% increased risk among high parity women.
However, in that study there was no regular trend with increasing
parity. In the same study, age at ﬁrst birth was not associated
with RCC risk after adjustment for age, study centre, body mass
index and number of births (Lindblad et al, 1995). Compared
to women with one or two births, multiparous women showed
a more than two-fold risk increase, an association that was stron-
ger among hypertensive or overweight women (Chow et al, 1995).
In another study, a risk increase of similar magnitude was
reported in multiparous women compared to nulliparous women,
which was strictly limited to women with a previous history of
foetal loss; among women with no foetal loss, the number of live
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Table 1 Distribution of 1465 case women with renal cell cancer, by year
of birth and age at diagnosis
Cases (n=1465)
No (%)
Year of birth
1925–29 581 (39.7)
1930–39 614 (41.9)
1940–49 218 (14.9)
1950–72 52 (3.5)
Age at diagnosis (years)
16–39 199 (13.6)
40–49 389 (26.6)
50–59 649 (44.3)
60–67 228 (15.6)
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latter study, as in our own, showed evidence of an inverse asso-
ciation between age at ﬁrst birth and the risk of RCC.
The main strengths of the present study were its large size and
the population-based design that minimised selection and informa-
tion biases. By using nation-wide registry information, we were
able to ascertain virtually all incident cases of RCC. The primary
weakness was the absence of information on potential confounders
such as Body Mass Index (BMI), weight cycling, hypertension, and
smoking habits. Furthermore, in our assessment, pregnancy
histories on complications or outcomes such as spontaneous and
induced abortions were not available.
Of particular concern was the inﬂuence on our risk estimates
by uncontrolled confounding by BMI. Childbearing is associated
with a considerable increase in weight, usually followed by some
degree of permanent weight-retention after delivery and lactation
(Ro ¨ssner, 1997). Results from a meta-analysis of 14 studies on
obesity and the risk of RCC in women, indicate that the risk
increases by 7% for each unit increase in BMI (Bergstrom et al,
2001).
Thus, pregnancy-associated weight gain may have inﬂuenced the
observed relation to parity. To indirectly assess the relative impor-
tance of parity and BMI, we obtained data from the Swedish
Medical Birth Register, a population-based database that since
1992 records pre-pregnancy weight among expecting mothers.
These data showed that pre-pregnancy BMI increased by an aver-
age of 3.3 units between a ﬁrst and sixth pregnancy (Table 4),
producing an expected risk increase for RCC equalling 25.0%
(1.07
3.3). In the present study, we found an estimated risk increase
of 62% for women of parity 5+, relative to uniparous women.
Taken together, these data provide evidence of an independent
risk-modifying effect of parity on the risk of developing RCC, over
and beyond the inﬂuence of BMI. This assumption is supported by
the ﬁndings of the collaborative international study on renal cell
cancer, where neither adjustment for smoking nor body mass index
altered the estimates for parity (Lindblad et al, 1995). Chow et al
(1995) reported an interaction between parity, obesity and the risk
of RCC. In that study, the positive association with number of
births was present in women with normal weight, but was stronger
among obese subjects.
We can only speculate about the biological mechanisms whereby
childbearing could affect renal carcinogenesis. Pregnancy-associated
hormonal changes, particularly high oestrogen levels, may act as
promotors of malignant change by stimulating renal cell prolifera-
tion either directly or via paracrine growth factors (Concolino et al,
1993). Both oestrogen and progesterone receptors are present in
normal and malignant renal cells (Ronchi et al, 1984). High doses
of potent oestrogens have been shown to induce renal cell tumours
in laboratory rodents (Li and Li, 1990). The proliferative effect of
oestrogen on kidney tissue seen experimentally may be mediated
through the up-regulation of IGF-I receptors (Chen et al, 1996).
Also, both insulin and IGF-I might contribute to the growth and
proliferation of renal cell cancer. Experimentally evidence indicates
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Table 2 Distribution of 1465 women with renal cell cancer and 7320 controls by number of live births and
age at ﬁrst birth. Odds ratios (OR) and 95% conﬁdence intervals (CI) by parity and age at ﬁrst birth
No. (%) Odds ratio (95% CI)
Cases Controls Adjusted for age Adjusted
a
Nulliparous 173 (11.8) 1155 (15.8) 1.00 –
Ever-parous 1292 (88.2) 6165 (84.2) 1.42 (1.19–1.69) –
No of births
0 173 (11.8) 1155 (15.8) 0.86 (0.69–1.06) –
1 248 (16.9) 1439 (19.7) 1.00 1.00
2 519 (35.4) 2639 (36.1) 1.15 (0.97–1.35) 1.11 (0.94–1.32)
3 327 (22.3) 1377 (18.8) 1.39 (1.16–1.66) 1.33 (1.10–1.61)
4 128 (8.7) 458 (6.3) 1.64 (1.29–2.08) 1.53 (1.19–1.97)
5+ 70 (4.8) 252 (3.4) 1.64 (1.22–2.21) 1.62 (1.18–2.23)
Trend per pregnancy 1.16 (1.11–1.22)
(P=0.0001)
1.15 (1.08–1.22)
(P=0.0001)
Age at ﬁrst birth (years)
Nulliparous 173 (11.8) 1155 (15.8) 0.65 (0.52–0.81) –
520 223 (15.2) 979 (13.4) 1.00 1.00
20–24 620 (42.3) 2815 (38.5) 0.97 (0.81–1.14) 0.99 (0.84–1.18)
25–29 323 (22.1) 1647 (22.5) 0.86 (0.71–1.04) 0.94 (0.77–1.15)
530 126 (8.6) 724 (9.9) 0.76 (0.60–0.97) 0.89 (0.69–1.15)
Trend per 5 years 0.88 (0.82–0.94) 0.92 (0.86–1.00)
(among parous women)
b (P=0.0003) (P=0.04)
aAmong parous women, adjusted for age and mutually for number of births and age at ﬁrst birth.
bContinuous trend.
Table 3 Odds ratios (OR) with 95% conﬁdence intervals (CI) of
developing RCC in uniparous, biparous, triparous and ever-parous women
compared with nulliparous women, by years since most recent birth
Years since most
Parity recent birth No of cases OR
a 95% CI
1 0–14 49 1.3 (0.8–2.0)
15–19 27 0.9 (0.5–1.5)
20–24 50 1.2 (0.8–1.9)
25–29 33 0.8 (0.5–1.3)
30+ 89 1.1 (0.7–1.6)
2 0–14 115 1.2 (0.9–1.7)
15–19 90 1.4 (1.0–2.0)
20–24 94 1.1 (0.8–1.5)
25–29 106 1.3 (0.9–1.7)
30+ 114 1.2 (0.9–1.7)
3 0–14 86 1.8 (1.2–2.6)
15–19 58 2.0 (1.3–3.1)
20–24 73 1.5 (1.0–2.2)
25–29 67 1.7 (1.1–2.6)
30+ 43 1.8 (1.1–3.0)
Ever-parous 0–14 304 1.5 (1.2–1.9)
15–19 219 1.5 (1.2–1.9)
20–24 271 1.4 (1.2–1.8)
25–29 231 1.3 (1.0–1.6)
30+ 267 1.3 (1.1–1.7)
aOdds ratios are relative to nulliparous women.
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renal diseases, including renal tumours (Zumkeller and Schoﬁeld,
1992; Stadler and Vogelzang, 1993; Kellerer et al, 1995). The
consistent ﬁnding that obesity is a risk factor for human renal cell
cancer, and the knowledge that obesity may lead to a hyperestro-
genic environment and increased levels of insulin and insulin-like
growth factor (IGF-1) (Azziz, 1989; Frystyk et al, 1995), provides
indirect support that hormonal factors may play a role in human
renal carcinogenesis. Also, epidemiological studies indicate that
patients with diabetes have an increased risk of renal cell cancer
(Schlehofer et al, 1996; Lindblad et al, 1999). In addition, a normal
pregnancy is associated with hyperﬁltration (Krutzen et al, 1992;
Sturgiss et al, 1996). Animal studies suggest that glomerular hyper-
ﬁltration could play a role in the development of
glomerulosclerosis, (Neuringer and Brenner, 1992; Westenend et
al, 1992), which makes the nephrons more vulnerable for exposure
to carcinogens.
The results of the present study are interesting because of both
the highly regular trend between increasing parity and the risk of
RCC, and the strength of the associations. Our observations appear
unlikely to be fully explained by uncontrolled confounding and
warrant further evaluation in large studies where detailed informa-
tion on other risk factors for RCC and possible confounders also
can be considered.
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